Casdin Capital, Llc Sema4 Holdings Corp. (SMFR) insider trading activity

Casdin Capital, LLC is Director of Sema4 Holdings Corp.. Currently has a direct ownership of 3.51 Million shares of SMFR, which is worth approximately $1.19 Million. The most recent transaction as insider was on Aug 01, 2024, when has been sold 413,655 shares (Class A Common Stock) at a price of $32.25 per share, resulting in proceeds of $13,340,373. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.51M

0% 3M change

n/a 12M change

Total Value Held $1.19 Million

Casdin Capital, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2024	BUY Other acquisition or disposition	$13,340,373 $32.25 p/Share	413,655 Added 10.55%	3,507,164 Class A Common Stock
Jun 04 2024	BUY Open market or private purchase	$675,600 $22.52 p/Share	30,000 Added 0.96%	3,093,509 Class A Common Stock
Jun 03 2024	BUY Open market or private purchase	$2,082,000 $20.82 p/Share	100,000 Added 3.16%	3,063,509 Class A Common Stock
May 29 2024	BUY Open market or private purchase	$842,800 $21.07 p/Share	40,000 Added 1.33%	2,963,509 Class A Common Stock
May 28 2024	BUY Open market or private purchase	$377,245 $20.61 p/Share	18,304 Added 0.62%	2,923,509 Class A Common Stock
May 24 2024	BUY Open market or private purchase	$2,901,223 $20.12 p/Share	144,196 Added 4.73%	2,905,205 Class A Common Stock
May 23 2024	BUY Open market or private purchase	$146,925 $19.59 p/Share	7,500 Added 0.27%	2,761,009 Class A Common Stock
May 13 2024	BUY Open market or private purchase	$1,165,500 $23.31 p/Share	50,000 Added 1.78%	2,753,509 Class A Common Stock
Mar 05 2024	BUY Open market or private purchase	$7,947 $8.83 p/Share	900 Added 0.03%	2,703,509 Class A Common Stock
Mar 04 2024	BUY Open market or private purchase	$349,600 $8.74 p/Share	40,000 Added 1.46%	2,702,609 Class A Common Stock

Also insider at

CNST

CONSTELLATION PHARMACEUTICALS INC Healthcare

> 10% Shareholder

FULC

Fulcrum Therapeutics, Inc. Healthcare

> 10% Shareholder

GBIO

Generation Bio Co. Healthcare

> 10% Shareholder

TSVT

2seventy bio, Inc. Healthcare

Director

CCL